Stony Brook, NY, United States of America

Yupo Ma

This inventor holds 7 USPTO granted patents and 15 published patent applications and 3 EPO patents. Top assignee: Icell Gene Therapeutics LLC. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yupo Ma. Retrieved from https://idiyas.com/inventor/yupo-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 15)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

7 out of 7

Icell Gene Therapeutics LLC

patents

Years Active: 2019-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735471 - CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOF (2026-09-15),

2. 12275787 - Chimeric antigen receptors (CARs), compositions and methods thereof (2025-04-14),

3. 11905528 - Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof (2024-02-20),

4. 11820819 - Chimeric antigen receptors (CARs), compositions and methods thereof (2023-11-21),

5. 11655452 - Chimeric antigen receptors (CARs), compositions and methods of use thereof (2023-05-23),

6. 11173179 - Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof (2021-11-16),

7. 10273280 - Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositions and methods of use thereof (2019-04-30),

Title: Yupo Ma: Innovator in Chimeric Antigen Receptors

Introduction

Yupo Ma is a prominent inventor based in Stony Brook, NY (US), known for his significant contributions to the field of gene therapy. He holds a total of six patents, showcasing his innovative approach to medical treatments and therapies.

Latest Patents

Among his latest patents is a groundbreaking invention related to chimeric antigen receptors (CARs), which includes compositions and methods for treating autoimmune diseases, asthma, and preventing or mediating organ rejection in subjects. This patent provides a method that could revolutionize treatment options for various conditions. Another notable patent involves a compound chimeric antigen receptor (cCAR) that targets multiple antigens. This invention includes engineered cells with distinct chimeric antigen receptor polypeptides, each containing unique components that enhance their functionality.

Career Highlights

Yupo Ma is affiliated with Icell Gene Therapeutics LLC, where he continues to push the boundaries of gene therapy and its applications. His work has the potential to significantly impact the medical field, particularly in the treatment of complex diseases.

Collaborations

Yupo collaborates with talented individuals such as Kevin Pinz and Xun Jiang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yupo Ma's contributions to the field of gene therapy, particularly through his patents on chimeric antigen receptors, highlight his role as a leading inventor. His work promises to advance medical treatments and improve patient outcomes in various health conditions.

Profile summary based on public USPTO records.